| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.928 | 0.001 | 0.928 | Alpha-N-acetylglucosaminidase inhibitor | 0.852 0.002 DB03947 0.573 0.004 DBMET02033 | ||
| 0.861 | 0.002 | 0.861 | Alcohol oxidase inhibitor | 0.674 0.003 DB03947 0.154 0.01 DBMET02033 | ||
| 0.807 | 0.004 | 0.807 | Hypoglycemic | 0.495 0.015 DB03947 | ||
| 0.798 | 0.004 | 0.798 | Aldehyde oxidase inhibitor | 0.748 0.005 DB03947 0.45 0.04 DBMET02033 | ||
| 0.798 | 0.007 | 0.839 | Cyclophilin D inhibitor | 0.839 0.005 DB03947 0.574 0.032 DBMET02033 | DB03947 | |
| 0.771 | 0 | 0.952 | Mannitol 2-dehydrogenase inhibitor | 0.952 0 DB03947 0.93 0 DBMET02033 | DB03947 | |
| 0.696 | 0.001 | 0.764 | Triose-phosphate isomerase inhibitor | 0.678 0.001 DB03947 0.764 0.001 DBMET02033 | DBMET02033 | |
| 0.662 | 0.003 | 0.662 | Chelator | 0.263 0.015 DB03947 0.151 0.035 DBMET02033 | ||
| 0.639 | 0.004 | 0.639 | Interleukin 6 antagonist | 0.323 0.012 DB03947 0.146 0.095 DBMET02033 | ||
| 0.633 | 0.007 | 0.633 | 5 Hydroxytryptamine release inhibitor | 0.547 0.02 DB03947 0.277 0.192 DBMET02033 | ||
| 0.631 | 0.009 | 0.631 | Immunosuppressant | 0.484 0.037 DB03947 0.545 0.022 DBMET02033 | ||
| 0.62 | 0.004 | 0.62 | Amylase inhibitor | 0.421 0.008 DB03947 0.231 0.034 DBMET02033 | ||
| 0.609 | 0.004 | 0.609 | Peroxidase inhibitor | 0.512 0.009 DB03947 0.23 0.052 DBMET02033 | ||
| 0.609 | 0.006 | 0.609 | Hypolipemic | 0.446 0.018 DB03947 0.446 0.018 DBMET02033 | ||
| 0.598 | 0.019 | 0.598 | Cholesterol antagonist | 0.514 0.03 DB03947 0.387 0.052 DBMET02033 | ||
| 0.581 | 0.002 | 0.581 | NADH dehydrogenase inhibitor | 0.419 0.004 DB03947 0.533 0.003 DBMET02033 | ||
| 0.581 | 0.004 | 0.581 | Hematopoietic | 0.107 0.029 DB03947 0.11 0.027 DBMET02033 | ||
| 0.586 | 0.016 | 0.586 | 5 Hydroxytryptamine release stimulant | 0.5 0.027 DB03947 0.181 0.139 DBMET02033 | ||
| 0.583 | 0.013 | 0.583 | Immunomodulator | |||
| 0.6 | 0.036 | 0.6 | Caspase 9 stimulant | 0.536 0.048 DB03947 0.442 0.087 DBMET02033 | ||
| 0.554 | 0.016 | 0.554 | Histamine release inhibitor | 0.472 0.039 DB03947 | ||
| 0.528 | 0.002 | 0.528 | UDP-glucose 4-epimerase inhibitor | 0.491 0.003 DB03947 0.518 0.002 DBMET02033 | ||
| 0.531 | 0.023 | 0.531 | Vasodilator, peripheral | 0.453 0.04 DB03947 0.269 0.114 DBMET02033 | ||
| 0.512 | 0.014 | 0.512 | Vasodilator, coronary | 0.401 0.035 DB03947 0.274 0.11 DBMET02033 | ||
| 0.496 | 0.014 | 0.496 | DNA synthesis inhibitor | 0.388 0.023 DB03947 0.479 0.015 DBMET02033 | ||
| 0.488 | 0.008 | 0.85 | Hepatoprotectant | 0.85 0.002 DB03947 0.701 0.004 DBMET02033 | DB03947 | |
| 0.468 | 0.003 | 0.468 | Phenylalanine 4-hydroxylase inhibitor | 0.327 0.004 DB03947 0.097 0.027 DBMET02033 | ||
| 0.468 | 0.002 | 0.568 | Phosphofructokinase-1 inhibitor | 0.369 0.004 DB03947 0.568 0.002 DBMET02033 | DBMET02033 | |
| 0.442 | 0.017 | 0.442 | Vasodilator | 0.217 0.091 DB03947 | ||
| 0.506 | 0.085 | 0.506 | Antiinflammatory | 0.412 0.132 DB03947 0.433 0.12 DBMET02033 | ||
| 0.412 | 0.003 | 0.444 | Carbamoyl phosphate synthetase inhibitor | 0.366 0.004 DB03947 0.444 0.003 DBMET02033 | DBMET02033 | |
| 0.443 | 0.038 | 0.469 | Immunostimulant | 0.394 0.051 DB03947 0.469 0.033 DBMET02033 | DBMET02033 | |
| 0.43 | 0.027 | 0.43 | Interleukin antagonist | 0.372 0.035 DB03947 | ||
| 0.446 | 0.043 | 0.446 | GABA C receptor rho-3 antagonist | 0.334 0.095 DB03947 | ||
| 0.403 | 0.002 | 0.403 | Plasmepsin I inhibitor | |||
| 0.403 | 0.004 | 0.403 | Succinate dehydrogenase inhibitor | 0.387 0.004 DB03947 0.251 0.022 DBMET02033 | ||
| 0.4 | 0.004 | 0.4 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.371 0.004 DB03947 0.365 0.004 DBMET02033 | ||
| 0.397 | 0.002 | 0.397 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.29 0.004 DB03947 0.364 0.002 DBMET02033 | ||
| 0.423 | 0.031 | 0.423 | Antioxidant | 0.214 0.105 DB03947 0.163 0.15 DBMET02033 | ||
| 0.39 | 0.003 | 0.39 | Mannose-6-phosphate isomerase inhibitor | 0.272 0.008 DB03947 0.365 0.004 DBMET02033 | ||
| 0.391 | 0.005 | 0.391 | Growth factor agonist | |||
| 0.397 | 0.013 | 0.397 | Diuretic | 0.156 0.072 DB03947 | ||
| 0.395 | 0.028 | 0.395 | Superoxide dismutase inhibitor | 0.347 0.037 DB03947 | ||
| 0.43 | 0.064 | 0.44 | Antibacterial | 0.363 0.095 DB03947 0.44 0.06 DBMET02033 | DBMET02033 | |
| 0.368 | 0.005 | 0.368 | Expectorant | 0.25 0.013 DB03947 0.211 0.018 DBMET02033 | ||
| 0.36 | 0.002 | 0.36 | Alpha-mannosidase inhibitor | 0.184 0.003 DB03947 0.09 0.008 DBMET02033 | ||
| 0.357 | 0.003 | 0.359 | Biliverdin reductase inhibitor | 0.211 0.005 DB03947 0.359 0.002 DBMET02033 | DBMET02033 | |
| 0.36 | 0.006 | 0.36 | GABA C receptor agonist | 0.252 0.013 DB03947 0.113 0.055 DBMET02033 | ||
| 0.351 | 0.006 | 0.351 | Hexokinase inhibitor | 0.222 0.025 DB03947 0.302 0.011 DBMET02033 | ||
| 0.339 | 0.002 | 0.339 | Mannosidase inhibitor | 0.176 0.003 DB03947 0.079 0.009 DBMET02033 | ||
| 0.339 | 0.003 | 0.339 | Neuraminidase (influenza) inhibitor | 0.244 0.004 DB03947 | ||
| 0.34 | 0.004 | 0.34 | Mucolytic | 0.245 0.007 DB03947 0.201 0.013 DBMET02033 | ||
| 0.334 | 0.005 | 0.419 | Adenylate kinase inhibitor | 0.313 0.006 DB03947 0.419 0.003 DBMET02033 | DBMET02033 | |
| 0.342 | 0.014 | 0.342 | Peptidyltransferase inhibitor | 0.272 0.037 DB03947 0.169 0.149 DBMET02033 | ||
| 0.337 | 0.01 | 0.337 | Alkylator | 0.223 0.02 DB03947 0.315 0.012 DBMET02033 | ||
| 0.347 | 0.024 | 0.52 | Anesthetic general | 0.264 0.044 DB03947 0.52 0.007 DBMET02033 | DBMET02033 | |
| 0.331 | 0.009 | 0.331 | Aldehyde dehydrogenase inhibitor | 0.288 0.013 DB03947 0.243 0.019 DBMET02033 | ||
| 0.33 | 0.01 | 0.33 | Insulin secretagoues | 0.156 0.069 DB03947 | ||
| 0.32 | 0.001 | 0.516 | Glucose-6-phosphate isomerase inhibitor | 0.396 0 DB03947 0.516 0 DBMET02033 | DBMET02033 | |
| 0.41 | 0.092 | 0.41 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.32 0.187 DB03947 | ||
| 0.324 | 0.008 | 0.404 | Interleukin 1b antagonist | 0.404 0.005 DB03947 0.102 0.079 DBMET02033 | DB03947 | |
| 0.348 | 0.041 | 0.348 | Sodium/bile acid cotransporter inhibitor | 0.264 0.113 DB03947 | ||
| 0.336 | 0.033 | 0.336 | Interleukin agonist | 0.252 0.078 DB03947 0.226 0.098 DBMET02033 | ||
| 0.349 | 0.046 | 0.349 | Interleukin 2 agonist | 0.265 0.103 DB03947 | ||
| 0.301 | 0.003 | 0.301 | Neuraminidase inhibitor | 0.231 0.004 DB03947 0.062 0.041 DBMET02033 | ||
| 0.316 | 0.026 | 0.316 | Tyrosine 3 hydroxylase inhibitor | 0.263 0.057 DB03947 | ||
| 0.301 | 0.011 | 0.301 | Nitric-oxide synthase stimulant | 0.256 0.029 DB03947 0.171 0.15 DBMET02033 | ||
| 0.348 | 0.065 | 0.393 | Antithrombotic | 0.277 0.106 DB03947 0.393 0.051 DBMET02033 | DBMET02033 | |
| 0.288 | 0.009 | 0.288 | Ferrochelatase inhibitor | 0.179 0.028 DB03947 | ||
| 0.281 | 0.004 | 0.281 | Sphingomyelinase inhibitor | 0.191 0.011 DB03947 0.218 0.007 DBMET02033 | ||
| 0.283 | 0.006 | 0.444 | Selectin antagonist | 0.444 0.003 DB03947 0.349 0.004 DBMET02033 | DB03947 | |
| 0.289 | 0.017 | 0.289 | Hemostatic | 0.13 0.096 DB03947 | ||
| 0.308 | 0.039 | 0.308 | Cyclic AMP phosphodiesterase inhibitor | 0.218 0.081 DB03947 | ||
| 0.33 | 0.064 | 0.33 | Calcium channel activator | 0.253 0.144 DB03947 0.272 0.122 DBMET02033 | ||
| 0.296 | 0.032 | 0.376 | RNA-directed DNA polymerase inhibitor | 0.221 0.073 DB03947 0.376 0.021 DBMET02033 | DBMET02033 | |
| 0.283 | 0.02 | 0.452 | Phospholipase C inhibitor | 0.21 0.038 DB03947 0.452 0.008 DBMET02033 | DBMET02033 | |
| 0.272 | 0.012 | 0.272 | MAP kinase kinase inhibitor | 0.13 0.065 DB03947 | ||
| 0.38 | 0.123 | 0.38 | Alpha-glucosidase inhibitor | |||
| 0.267 | 0.013 | 0.267 | Cell wall synthesis inhibitor | 0.184 0.038 DB03947 0.165 0.052 DBMET02033 | ||
| 0.292 | 0.038 | 0.299 | Gastrin inhibitor | 0.299 0.034 DB03947 | DB03947 | |
| 0.255 | 0.007 | 0.288 | Glutamate dehydrogenase inhibitor | 0.23 0.008 DB03947 0.288 0.006 DBMET02033 | DBMET02033 | |
| 0.257 | 0.008 | 0.257 | Catalase inhibitor | 0.24 0.009 DB03947 0.168 0.022 DBMET02033 | ||
| 0.295 | 0.048 | 0.295 | 5 Hydroxytryptamine uptake stimulant | 0.228 0.106 DB03947 | ||
| 0.253 | 0.008 | 0.253 | Microtubule formation inhibitor | 0.205 0.019 DB03947 0.133 0.048 DBMET02033 | ||
| 0.247 | 0.004 | 0.247 | Glutamate decarboxylase inhibitor | 0.234 0.005 DB03947 0.141 0.015 DBMET02033 | ||
| 0.283 | 0.041 | 0.283 | MAP kinase kinase 2 inhibitor | 0.158 0.114 DB03947 | ||
| 0.254 | 0.018 | 0.309 | Interleukin 1 antagonist | 0.309 0.01 DB03947 | DB03947 | |
| 0.244 | 0.009 | 0.244 | Histidine decarboxylase inhibitor | 0.207 0.012 DB03947 0.217 0.011 DBMET02033 | ||
| 0.241 | 0.007 | 0.241 | GABA C receptor antagonist | 0.157 0.026 DB03947 0.121 0.052 DBMET02033 | ||
| 0.237 | 0.005 | 0.237 | Keratolytic | 0.202 0.008 DB03947 0.186 0.01 DBMET02033 | ||
| 0.231 | 0.004 | 0.247 | Acyl-CoA dehydrogenase inhibitor | 0.203 0.005 DB03947 0.247 0.003 DBMET02033 | DBMET02033 | |
| 0.231 | 0.005 | 0.231 | Adenylate cyclase stimulant | 0.199 0.014 DB03947 0.182 0.024 DBMET02033 | ||
| 0.249 | 0.027 | 0.249 | Protein kinase stimulant | 0.187 0.047 DB03947 0.181 0.049 DBMET02033 | ||
| 0.259 | 0.039 | 0.259 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.233 0.051 DB03947 0.24 0.047 DBMET02033 | ||
| 0.231 | 0.011 | 0.231 | MAP kinase kinase 5 inhibitor | 0.183 0.057 DB03947 | ||
| 0.227 | 0.007 | 0.227 | Creatine kinase inhibitor | 0.171 0.016 DB03947 0.102 0.057 DBMET02033 | ||
| 0.229 | 0.012 | 0.229 | Arachidonic acid antagonist | 0.22 0.017 DB03947 0.226 0.014 DBMET02033 | ||
| 0.219 | 0.004 | 0.219 | HIV-1 protease inhibitor | 0.041 0.032 DB03947 | ||
| 0.288 | 0.075 | 0.288 | Spasmolytic | 0.167 0.147 DB03947 | ||
| 0.215 | 0.004 | 0.215 | Maillard reaction inhibitor | 0.081 0.024 DB03947 | ||
| 0.212 | 0.003 | 0.212 | Aconitate hydratase inhibitor | 0.195 0.003 DB03947 0.092 0.01 DBMET02033 | ||
| 0.314 | 0.107 | 0.66 | Antiobesity | 0.66 0.014 DB03947 | DB03947 | |
| 0.247 | 0.04 | 0.247 | Neurotrophic factor enhancer | 0.216 0.062 DB03947 0.15 0.137 DBMET02033 | ||
| 0.207 | 0.005 | 0.207 | Interferon agonist | 0.128 0.014 DB03947 0.093 0.035 DBMET02033 | ||
| 0.208 | 0.007 | 0.208 | GABA C receptor rho-1 antagonist | 0.141 0.025 DB03947 0.088 0.082 DBMET02033 | ||
| 0.218 | 0.017 | 0.218 | Aminopeptidase B inhibitor | 0.202 0.021 DB03947 0.145 0.04 DBMET02033 | ||
| 0.241 | 0.04 | 0.241 | Insulin sensitizer | 0.189 0.085 DB03947 | ||
| 0.244 | 0.043 | 0.244 | P-glycoprotein inhibitor | 0.154 0.111 DB03947 0.149 0.118 DBMET02033 | ||
| 0.231 | 0.032 | 0.231 | Interferon gamma antagonist | 0.175 0.053 DB03947 | ||
| 0.267 | 0.071 | 0.267 | DNA damaging | |||
| 0.2 | 0.007 | 0.2 | Aminopeptidase I inhibitor | 0.182 0.008 DB03947 0.131 0.016 DBMET02033 | ||
| 0.263 | 0.073 | 0.263 | Cardiotonic | |||
| 0.223 | 0.034 | 0.223 | Melanin inhibitor | 0.198 0.042 DB03947 0.158 0.071 DBMET02033 | ||
| 0.269 | 0.08 | 0.269 | Insulysin inhibitor | 0.229 0.118 DB03947 | ||
| 0.192 | 0.004 | 0.192 | Ca2+-transporting ATPase inhibitor | 0.174 0.01 DB03947 0.146 0.053 DBMET02033 | ||
| 0.201 | 0.014 | 0.201 | Mediator release inhibitor | 0.118 0.049 DB03947 | ||
| 0.211 | 0.024 | 0.245 | Cholesterol synthesis inhibitor | 0.168 0.036 DB03947 0.245 0.018 DBMET02033 | DBMET02033 | |
| 0.206 | 0.021 | 0.247 | Toll-Like receptor 2 antagonist | 0.167 0.041 DB03947 0.247 0.01 DBMET02033 | DBMET02033 | |
| 0.191 | 0.007 | 0.191 | Ornithine carbamoyltransferase inhibitor | 0.123 0.012 DB03947 0.153 0.009 DBMET02033 | ||
| 0.186 | 0.006 | 0.186 | MAP kinase kinase 1 inhibitor | 0.132 0.025 DB03947 | ||
| 0.199 | 0.021 | 0.199 | Antineoplastic antibiotic | 0.199 0.021 DB03947 0.094 0.049 DBMET02033 | ||
| 0.207 | 0.032 | 0.207 | ATPase inhibitor | 0.171 0.07 DB03947 | ||
| 0.262 | 0.09 | 0.262 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.185 | 0.014 | 0.202 | Alcohol dehydrogenase inhibitor | 0.202 0.012 DB03947 0.157 0.018 DBMET02033 | DB03947 | |
| 0.176 | 0.006 | 0.176 | Phosphorylase inhibitor | 0.063 0.023 DB03947 0.1 0.013 DBMET02033 | ||
| 0.171 | 0.002 | 0.171 | Neuraminidase (Influenza A) inhibitor | 0.12 0.004 DB03947 | ||
| 0.177 | 0.012 | 0.177 | Electrolyte absorption antagonist | 0.12 0.037 DB03947 | ||
| 0.169 | 0.004 | 0.169 | Glucosylceramidase inhibitor | 0.078 0.017 DB03947 | ||
| 0.183 | 0.018 | 0.183 | Protease inhibitor | 0.163 0.024 DB03947 0.123 0.045 DBMET02033 | ||
| 0.232 | 0.067 | 0.465 | Pyruvate kinase inhibitor | 0.277 0.054 DB03947 0.465 0.012 DBMET02033 | DBMET02033 | |
| 0.21 | 0.047 | 0.21 | 5 Hydroxytryptamine 3E antagonist | 0.179 0.109 DB03947 | ||
| 0.183 | 0.021 | 0.185 | Sphingosine 1-phosphate receptor 5 antagonist | 0.156 0.052 DB03947 0.185 0.02 DBMET02033 | DBMET02033 | |
| 0.197 | 0.035 | 0.197 | Cyclin-dependent kinase 3 inhibitor | 0.139 0.125 DB03947 | ||
| 0.181 | 0.024 | 0.181 | MAP kinase kinase 4 inhibitor | 0.138 0.09 DB03947 | ||
| 0.184 | 0.028 | 0.184 | Cystathionine beta-synthase inhibitor | 0.135 0.048 DB03947 | ||
| 0.172 | 0.016 | 0.198 | Porphobilinogen synthase inhibitor | 0.159 0.019 DB03947 0.198 0.012 DBMET02033 | DBMET02033 | |
| 0.171 | 0.019 | 0.183 | Sphingosine 1-phosphate receptor 4 antagonist | 0.15 0.034 DB03947 0.183 0.014 DBMET02033 | DBMET02033 | |
| 0.185 | 0.033 | 0.278 | DNA polymerase I inhibitor | 0.154 0.047 DB03947 0.278 0.013 DBMET02033 | DBMET02033 | |
| 0.156 | 0.004 | 0.242 | Sphingosine 1-phosphate receptor 3 agonist | 0.072 0.009 DB03947 0.242 0.003 DBMET02033 | DBMET02033 | |
| 0.188 | 0.036 | 0.188 | GABA C receptor rho-2 antagonist | 0.14 0.088 DB03947 | ||
| 0.229 | 0.08 | 0.229 | Angiogenesis stimulant | 0.17 0.11 DBMET02033 | ||
| 0.208 | 0.065 | 0.208 | DNA methyltransferase I inhibitor | 0.16 0.094 DB03947 | ||
| 0.156 | 0.017 | 0.176 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.105 0.035 DB03947 0.176 0.013 DBMET02033 | DBMET02033 | |
| 0.141 | 0.004 | 0.163 | Fumarate hydratase inhibitor | 0.119 0.004 DB03947 0.163 0.004 DBMET02033 | DBMET02033 | |
| 0.199 | 0.067 | 0.199 | Nitric oxide antagonist | 0.158 0.089 DB03947 | ||
| 0.166 | 0.035 | 0.166 | Antibacterial (Helicobacter pylori) | |||
| 0.14 | 0.01 | 0.14 | Sphingosine 1-phosphate receptor 4 agonist | 0.087 0.032 DB03947 0.127 0.014 DBMET02033 | ||
| 0.135 | 0.006 | 0.135 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.093 0.012 DB03947 | ||
| 0.15 | 0.021 | 0.15 | DOPA decarboxylase inhibitor | 0.142 0.026 DB03947 0.146 0.024 DBMET02033 | ||
| 0.164 | 0.037 | 0.164 | Cyclooxygenase 3 inhibitor | 0.124 0.073 DB03947 0.122 0.075 DBMET02033 | ||
| 0.138 | 0.012 | 0.138 | Histone deacetylase stimulant | |||
| 0.138 | 0.012 | 0.138 | Histone deacetylase SIRT1 stimulant | |||
| 0.203 | 0.077 | 0.203 | DNA methylase inhibitor | 0.152 0.115 DB03947 | ||
| 0.187 | 0.062 | 0.187 | Tumour necrosis factor antagonist | |||
| 0.135 | 0.012 | 0.135 | Toll-Like receptor 2 agonist | 0.066 0.019 DB03947 | ||
| 0.156 | 0.033 | 0.165 | Sphingosine 1-phosphate receptor 2 antagonist | 0.128 0.078 DB03947 0.165 0.025 DBMET02033 | DBMET02033 | |
| 0.126 | 0.004 | 0.126 | Epithelial sodium channel blocker | 0.068 0.019 DB03947 | ||
| 0.143 | 0.022 | 0.143 | Anabolic | 0.132 0.029 DB03947 0.143 0.022 DBMET02033 | ||
| 0.16 | 0.039 | 0.16 | Adenylate cyclase inhibitor | 0.117 0.07 DB03947 0.137 0.054 DBMET02033 | ||
| 0.13 | 0.01 | 0.13 | Glycine receptor agonist | 0.093 0.026 DB03947 | ||
| 0.128 | 0.011 | 0.128 | Cathepsin D inhibitor | |||
| 0.142 | 0.025 | 0.142 | Calcium antagonist | 0.098 0.049 DB03947 | ||
| 0.131 | 0.016 | 0.131 | Glutamate release inhibitor | 0.116 0.025 DB03947 | ||
| 0.16 | 0.045 | 0.16 | Anesthetic local | 0.096 0.087 DB03947 | ||
| 0.128 | 0.014 | 0.155 | Argininosuccinate synthase inhibitor | 0.12 0.015 DB03947 0.155 0.011 DBMET02033 | DBMET02033 | |
| 0.138 | 0.026 | 0.138 | Androgen antagonist | 0.078 0.068 DB03947 | ||
| 0.155 | 0.043 | 0.155 | Cathepsin H inhibitor | 0.139 0.055 DB03947 | ||
| 0.119 | 0.008 | 0.119 | GABA B receptor agonist | 0.104 0.014 DB03947 0.072 0.062 DBMET02033 | ||
| 0.116 | 0.005 | 0.116 | Sphingosine kinase inhibitor | 0.085 0.013 DB03947 0.057 0.045 DBMET02033 | ||
| 0.129 | 0.018 | 0.129 | Phosphodiesterase 6D inhibitor | 0.114 0.031 DB03947 0.1 0.052 DBMET02033 | ||
| 0.131 | 0.021 | 0.131 | Lanosterol 14 alpha demethylase inhibitor | 0.107 0.046 DB03947 | ||
| 0.113 | 0.005 | 0.113 | Prostaglandin agonist | 0.086 0.006 DB03947 | ||
| 0.189 | 0.08 | 0.189 | Non-steroidal antiinflammatory agent | 0.147 0.119 DBMET02033 | ||
| 0.148 | 0.041 | 0.192 | Vanilloid 1 agonist | 0.139 0.052 DB03947 0.192 0.014 DBMET02033 | DBMET02033 | |
| 0.116 | 0.012 | 0.116 | Estrogen-related receptor beta agonist | 0.1 0.024 DB03947 | ||
| 0.134 | 0.03 | 0.134 | Prolactin inhibitor | 0.086 0.072 DB03947 | ||
| 0.11 | 0.006 | 0.132 | Phosphoglycerate kinase inhibitor | 0.082 0.008 DB03947 0.132 0.005 DBMET02033 | DBMET02033 | |
| 0.108 | 0.005 | 0.108 | Renin inhibitor | 0.031 0.03 DB03947 | ||
| 0.201 | 0.1 | 0.201 | Platelet antagonist | 0.185 0.113 DBMET02033 | ||
| 0.118 | 0.017 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.106 0.026 DB03947 0.099 0.032 DBMET02033 | ||
| 0.164 | 0.063 | 0.219 | Phospholipase A2 inhibitor | 0.145 0.079 DB03947 0.219 0.034 DBMET02033 | DBMET02033 | |
| 0.105 | 0.006 | 0.105 | Sphingosine kinase 2 inhibitor | 0.074 0.019 DB03947 0.069 0.023 DBMET02033 | ||
| 0.107 | 0.008 | 0.107 | Glutamate (mGluR6) antagonist | 0.085 0.019 DB03947 0.106 0.008 DBMET02033 | ||
| 0.131 | 0.033 | 0.131 | HIV-1 integrase (Overall Integration) inhibitor | 0.115 0.043 DB03947 | ||
| 0.137 | 0.04 | 0.137 | Photosensitizer | 0.123 0.054 DB03947 | ||
| 0.106 | 0.009 | 0.106 | Prostaglandin F2 alpha antagonist | 0.061 0.045 DB03947 | ||
| 0.121 | 0.025 | 0.121 | Ornithine decarboxylase inhibitor | 0.105 0.039 DB03947 0.097 0.048 DBMET02033 | ||
| 0.146 | 0.05 | 0.146 | Nav1.3 sodium channel blocker | |||
| 0.1 | 0.005 | 0.1 | Sphingosine 1-phosphate receptor agonist | 0.055 0.021 DB03947 0.1 0.005 DBMET02033 | ||
| 0.147 | 0.052 | 0.147 | Heat shock protein 70 antagonist | 0.143 0.063 DBMET02033 | ||
| 0.155 | 0.06 | 0.155 | MAP kinase 3 inhibitor | |||
| 0.149 | 0.055 | 0.149 | Nav1.6 sodium channel blocker | |||
| 0.108 | 0.014 | 0.108 | Purinergic P2X1 antagonist | 0.074 0.029 DB03947 0.096 0.018 DBMET02033 | ||
| 0.204 | 0.112 | 0.204 | Neuropeptide Y2 antagonist | |||
| 0.115 | 0.023 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.104 0.035 DB03947 | ||
| 0.103 | 0.011 | 0.103 | Interferon inducer | 0.068 0.037 DB03947 | ||
| 0.15 | 0.06 | 0.15 | MAP3K9 inhibitor | |||
| 0.093 | 0.005 | 0.099 | Sphingosine 1-phosphate receptor 1 agonist | 0.057 0.014 DB03947 0.099 0.004 DBMET02033 | DBMET02033 | |
| 0.111 | 0.023 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.049 DB03947 | ||
| 0.098 | 0.01 | 0.098 | Exportin-1 inhibitor | 0.086 0.019 DB03947 | ||
| 0.094 | 0.006 | 0.094 | Adenosine deaminase inhibitor | 0.075 0.011 DB03947 0.054 0.026 DBMET02033 | ||
| 0.103 | 0.015 | 0.103 | Vanilloid 4 agonist | 0.08 0.041 DB03947 | ||
| 0.113 | 0.027 | 0.113 | Glutathione S-transferase inhibitor | 0.09 0.048 DB03947 0.091 0.047 DBMET02033 | ||
| 0.101 | 0.014 | 0.101 | Beta 3 adrenoreceptor antagonist | 0.068 0.037 DB03947 | ||
| 0.129 | 0.043 | 0.316 | Sphingosine 1-phosphate receptor 2 agonist | 0.316 0.004 DBMET02033 | DBMET02033 | |
| 0.088 | 0.003 | 0.088 | Prostaglandin EP2 agonist | 0.043 0.007 DB03947 | ||
| 0.103 | 0.019 | 0.103 | Ribonucleoside-diphosphate reductase inhibitor | 0.067 0.03 DB03947 0.095 0.02 DBMET02033 | ||
| 0.104 | 0.02 | 0.104 | Ribonucleotide reductase inhibitor | 0.069 0.031 DB03947 0.099 0.021 DBMET02033 | ||
| 0.098 | 0.014 | 0.098 | MAP kinase kinase 7 inhibitor | 0.082 0.04 DB03947 | ||
| 0.189 | 0.106 | 0.189 | Free radical scavenger | |||
| 0.086 | 0.005 | 0.086 | Sphingosine kinase 1 inhibitor | 0.058 0.01 DB03947 0.039 0.034 DBMET02033 | ||
| 0.092 | 0.01 | 0.092 | MDM2 inhibitor | 0.086 0.014 DB03947 | ||
| 0.09 | 0.009 | 0.09 | Calcium channel P-type blocker | 0.068 0.032 DB03947 | ||
| 0.144 | 0.064 | 0.284 | Bone formation stimulant | 0.284 0.019 DBMET02033 | DBMET02033 | |
| 0.152 | 0.072 | 0.152 | CF transmembrane conductance regulator agonist | |||
| 0.087 | 0.007 | 0.11 | Lysophosphatidic acid 3 receptor antagonist | 0.067 0.016 DB03947 0.11 0.004 DBMET02033 | DBMET02033 | |
| 0.097 | 0.018 | 0.097 | Beta adrenoreceptor antagonist | 0.068 0.042 DB03947 | ||
| 0.082 | 0.003 | 0.082 | Uridine phosphorylase inhibitor | 0.064 0.005 DB03947 0.049 0.008 DBMET02033 | ||
| 0.103 | 0.025 | 0.103 | GABA aminotransferase inhibitor | 0.074 0.055 DB03947 | ||
| 0.12 | 0.043 | 0.212 | Toll-Like receptor 4 antagonist | 0.1 0.07 DB03947 0.212 0.005 DBMET02033 | DBMET02033 | |
| 0.122 | 0.045 | 0.122 | Carbonic anhydrase XV inhibitor | 0.1 0.067 DB03947 | ||
| 0.094 | 0.018 | 0.094 | Phospholipase D inhibitor | 0.067 0.061 DB03947 | ||
| 0.119 | 0.045 | 0.119 | Carbonic anhydrase III inhibitor | 0.092 0.072 DB03947 | ||
| 0.078 | 0.004 | 0.078 | Prostaglandin E2 agonist | 0.031 0.01 DB03947 | ||
| 0.095 | 0.021 | 0.095 | Secretase beta inhibitor | 0.067 0.054 DB03947 | ||
| 0.086 | 0.014 | 0.086 | Beta 1 adrenoreceptor antagonist | 0.063 0.032 DB03947 | ||
| 0.159 | 0.087 | 0.189 | 3C-like protease (Human coronavirus) inhibitor | 0.189 0.058 DB03947 | DB03947 | |
| 0.105 | 0.034 | 0.105 | Adrenaline agonist | |||
| 0.074 | 0.004 | 0.074 | Guanylate cyclase inhibitor | 0.07 0.005 DB03947 0.066 0.007 DBMET02033 | ||
| 0.075 | 0.005 | 0.075 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.054 0.008 DB03947 0.053 0.008 DBMET02033 | ||
| 0.101 | 0.032 | 0.101 | mTOR complex 2 inhibitor | 0.081 0.065 DB03947 | ||
| 0.091 | 0.022 | 0.091 | Prostaglandin EP2 antagonist | |||
| 0.104 | 0.039 | 0.104 | ALK inhibitor | |||
| 0.074 | 0.01 | 0.074 | Adenylate cyclase 1 inhibitor | 0.044 0.035 DB03947 | ||
| 0.073 | 0.01 | 0.073 | Heparanase inhibitor | 0.054 0.035 DB03947 0.05 0.044 DBMET02033 | ||
| 0.123 | 0.06 | 0.123 | Monophenol monooxygenase inhibitor | 0.1 0.076 DB03947 | ||
| 0.133 | 0.07 | 0.133 | Nav1.2 sodium channel blocker | |||
| 0.073 | 0.01 | 0.073 | Thymidine kinase inhibitor | 0.054 0.016 DB03947 0.058 0.014 DBMET02033 | ||
| 0.117 | 0.055 | 0.117 | Protein kinase C gamma inhibitor | |||
| 0.069 | 0.007 | 0.069 | GABA uptake inhibitor | 0.044 0.021 DB03947 | ||
| 0.099 | 0.038 | 0.106 | Carbonic anhydrase XIII inhibitor | 0.077 0.052 DB03947 0.106 0.035 DBMET02033 | DBMET02033 | |
| 0.165 | 0.104 | 0.165 | Psychostimulant | 0.141 0.125 DBMET02033 | ||
| 0.071 | 0.01 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.057 0.033 DB03947 | ||
| 0.116 | 0.056 | 0.132 | Falcipain 3 inhibitor | 0.132 0.046 DB03947 | DB03947 | |
| 0.067 | 0.009 | 0.067 | Dopamine beta hydroxylase inhibitor | |||
| 0.072 | 0.015 | 0.072 | Beta 2 adrenoreceptor antagonist | 0.05 0.036 DB03947 | ||
| 0.059 | 0.003 | 0.075 | Lysophosphatidic acid receptor 1 agonist | 0.04 0.005 DB03947 0.075 0.002 DBMET02033 | DBMET02033 | |
| 0.073 | 0.018 | 0.073 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.212 | 0.157 | 0.212 | Transcription factor NF kappa B inhibitor | |||
| 0.064 | 0.01 | 0.064 | Microtubule stabilization | 0.042 0.039 DB03947 | ||
| 0.093 | 0.04 | 0.093 | D-Ala-D-Ala ligase inhibitor | 0.079 0.071 DB03947 0.083 0.061 DBMET02033 | ||
| 0.056 | 0.003 | 0.056 | Ileal bile acid transport inhibitor | 0.019 0.01 DB03947 | ||
| 0.144 | 0.092 | 0.144 | Growth hormone agonist | |||
| 0.053 | 0.002 | 0.072 | Lysophosphatidic acid receptor 3 agonist | 0.03 0.004 DB03947 0.072 0.002 DBMET02033 | DBMET02033 | |
| 0.068 | 0.017 | 0.068 | Pregnane X receptor antagonist | 0.055 0.046 DB03947 | ||
| 0.091 | 0.042 | 0.091 | Glycine receptor antagonist | |||
| 0.065 | 0.016 | 0.065 | Squalene epoxidase inhibitor | 0.046 0.044 DB03947 | ||
| 0.054 | 0.005 | 0.054 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.053 | 0.006 | 0.053 | HMG CoA reductase inhibitor | 0.038 0.017 DB03947 0.032 0.029 DBMET02033 | ||
| 0.052 | 0.004 | 0.056 | Prostaglandin F2 alpha agonist | 0.056 0.004 DB03947 0.025 0.012 DBMET02033 | DB03947 | |
| 0.053 | 0.006 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.015 DB03947 | ||
| 0.056 | 0.009 | 0.056 | Glutamate (mGluR8) agonist | 0.043 0.018 DB03947 0.054 0.009 DBMET02033 | ||
| 0.052 | 0.006 | 0.052 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.077 | 0.031 | 0.077 | Glutamate (mGluR7) antagonist | |||
| 0.076 | 0.031 | 0.076 | NMDA receptor glycine site agonist | |||
| 0.191 | 0.147 | 0.191 | Transcription factor STAT3 inhibitor | 0.191 0.146 DBMET02033 | ||
| 0.07 | 0.026 | 0.075 | Sphingosine 1-phosphate receptor 3 antagonist | 0.075 0.021 DBMET02033 | DBMET02033 | |
| 0.055 | 0.01 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.045 0.021 DB03947 | ||
| 0.068 | 0.023 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.056 | 0.012 | 0.056 | Membrane dipeptidase inhibitor | 0.043 0.022 DB03947 0.037 0.03 DBMET02033 | ||
| 0.133 | 0.089 | 0.133 | Cytidine deaminase inhibitor | |||
| 0.078 | 0.033 | 0.078 | Neutrophil collagenase inhibitor | |||
| 0.058 | 0.015 | 0.058 | Cytokine production stimulant | 0.046 0.042 DB03947 | ||
| 0.052 | 0.008 | 0.094 | Lysophosphatidic acid 2 receptor antagonist | 0.094 0.004 DBMET02033 | DBMET02033 | |
| 0.053 | 0.011 | 0.053 | Kainate receptor agonist | 0.042 0.026 DB03947 | ||
| 0.094 | 0.052 | 0.171 | Aminoacyl-tRNA synthetase inhibitor | 0.171 0.014 DBMET02033 | DBMET02033 | |
| 0.067 | 0.026 | 0.067 | Protein 50S ribosomal subunit inhibitor | 0.048 0.043 DB03947 | ||
| 0.053 | 0.013 | 0.053 | Arginase inhibitor | 0.033 0.029 DB03947 | ||
| 0.103 | 0.063 | 0.103 | Nav1.1 sodium channel blocker | |||
| 0.088 | 0.048 | 0.088 | Carbonic anhydrase VI inhibitor | |||
| 0.097 | 0.058 | 0.097 | Potassium channel (Ca-activated) activator | |||
| 0.108 | 0.069 | 0.108 | Acetylcholine release stimulant | |||
| 0.121 | 0.082 | 0.121 | Sodium channel blocker | |||
| 0.078 | 0.04 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.055 | 0.017 | 0.055 | Geranyltranstransferase inhibitor | 0.05 0.023 DBMET02033 | ||
| 0.117 | 0.079 | 0.117 | DNA repair enzyme inhibitor | |||
| 0.042 | 0.005 | 0.042 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 DB03947 | ||
| 0.05 | 0.013 | 0.05 | Antibiotic Aminoglycoside-like | 0.037 0.024 DB03947 | ||
| 0.05 | 0.014 | 0.05 | Heme oxygenase inhibitor | 0.045 0.022 DB03947 | ||
| 0.111 | 0.075 | 0.111 | Interleukin 8 antagonist | |||
| 0.052 | 0.016 | 0.052 | Plasmepsin II inhibitor | |||
| 0.079 | 0.043 | 0.079 | Phosphodiesterase VI inhibitor | |||
| 0.042 | 0.006 | 0.042 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 DB03947 | ||
| 0.061 | 0.026 | 0.061 | Leukotriene C antagonist | 0.055 0.042 DB03947 | ||
| 0.04 | 0.005 | 0.04 | Vitamin D receptor antagonist | 0.028 0.008 DB03947 | ||
| 0.04 | 0.005 | 0.04 | Estrogen-related receptor gamma antagonist | 0.03 0.016 DB03947 | ||
| 0.051 | 0.016 | 0.051 | Calcitonin receptor agonist | 0.035 0.023 DB03947 | ||
| 0.044 | 0.009 | 0.044 | Lysine carboxypeptidase inhibitor | 0.028 0.017 DB03947 | ||
| 0.091 | 0.057 | 0.091 | Phosphodiesterase I inhibitor | |||
| 0.046 | 0.012 | 0.046 | Vanilloid 3 antagonist | 0.041 0.02 DBMET02033 | ||
| 0.037 | 0.003 | 0.037 | Neuraminidase (Influenza B) inhibitor | 0.028 0.005 DB03947 | ||
| 0.074 | 0.04 | 0.074 | Protein kinase C beta inhibitor | |||
| 0.073 | 0.039 | 0.073 | Glucagon-like peptide 1 agonist | |||
| 0.059 | 0.025 | 0.059 | Bombesin 2 receptor antagonist | |||
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | |||
| 0.095 | 0.062 | 0.095 | Bile acid receptor antagonist | |||
| 0.064 | 0.031 | 0.069 | Carbonic anhydrase VB inhibitor | 0.069 0.028 DBMET02033 | DBMET02033 | |
| 0.043 | 0.011 | 0.043 | Prostaglandin D2 agonist | 0.03 0.023 DB03947 | ||
| 0.068 | 0.037 | 0.068 | NMDA receptor agonist | |||
| 0.049 | 0.019 | 0.049 | Beta adrenoreceptor agonist | |||
| 0.04 | 0.01 | 0.04 | Glutamate (mGluR3) agonist | 0.032 0.022 DB03947 | ||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | 0.028 0.018 DB03947 | ||
| 0.054 | 0.024 | 0.054 | Aldosterone antagonist | |||
| 0.058 | 0.029 | 0.117 | Sphingosine 1-phosphate receptor 5 agonist | 0.117 0.006 DBMET02033 | DBMET02033 | |
| 0.038 | 0.008 | 0.038 | Purinergic P2Y15 antagonist | 0.028 0.021 DB03947 | ||
| 0.063 | 0.035 | 0.063 | Heat shock protein 90 beta antagonist | |||
| 0.032 | 0.004 | 0.032 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 DB03947 | ||
| 0.099 | 0.071 | 0.099 | Topoisomerase I inhibitor | |||
| 0.069 | 0.041 | 0.069 | Leukotriene antagonist | |||
| 0.059 | 0.031 | 0.059 | Dihydroorotate oxidase inhibitor | |||
| 0.042 | 0.014 | 0.042 | Ceramide glucosyltransferase inhibitor | |||
| 0.058 | 0.031 | 0.058 | Leukotriene B4 antagonist | |||
| 0.032 | 0.005 | 0.032 | Isoleucine-tRNA ligase inhibitor | 0.025 0.01 DB03947 | ||
| 0.059 | 0.032 | 0.078 | Sphingosine 1-phosphate receptor 1 antagonist | 0.062 0.026 DB03947 0.078 0.015 DBMET02033 | DBMET02033 | |
| 0.095 | 0.07 | 0.095 | Glutamate (mGluR7) agonist | 0.091 0.081 DBMET02033 | ||
| 0.054 | 0.029 | 0.066 | Antimetabolite | 0.066 0.023 DBMET02033 | DBMET02033 | |
| 0.061 | 0.035 | 0.061 | Ryanodine receptor antagonist | 0.056 0.051 DBMET02033 | ||
| 0.036 | 0.011 | 0.036 | Purinergic P2T antagonist | |||
| 0.029 | 0.004 | 0.029 | Thromboxane A2 agonist | 0.019 0.006 DB03947 | ||
| 0.029 | 0.004 | 0.029 | Carbonic anhydrase X inhibitor | 0.018 0.01 DB03947 | ||
| 0.029 | 0.004 | 0.029 | Carbonic anhydrase VIII inhibitor | 0.018 0.01 DB03947 | ||
| 0.039 | 0.014 | 0.039 | ATP citrate lysase inhibitor | 0.032 0.022 DB03947 | ||
| 0.062 | 0.038 | 0.062 | Cathepsin E inhibitor | |||
| 0.042 | 0.019 | 0.042 | VCAM-1 antagonist | |||
| 0.037 | 0.014 | 0.037 | Estrogen-related receptor beta antagonist | |||
| 0.027 | 0.003 | 0.027 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DB03947 0.026 0.003 DBMET02033 | ||
| 0.042 | 0.019 | 0.042 | VCAM antagonist | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR3) antagonist | |||
| 0.065 | 0.043 | 0.065 | Protease 3C (Human rhinovirus) inhibitor | 0.058 0.056 DB03947 | ||
| 0.097 | 0.075 | 0.097 | AMP-activated protein kinase stimulant | |||
| 0.026 | 0.004 | 0.026 | Antibiotic Anthracycline-like | 0.023 0.007 DB03947 | ||
| 0.032 | 0.01 | 0.032 | Thymidine phosphorylase inhibitor | |||
| 0.128 | 0.106 | 0.128 | Pregnane X receptor agonist | |||
| 0.142 | 0.122 | 0.142 | Neurotensin receptor agonist | |||
| 0.067 | 0.047 | 0.067 | Acetylcholine M5 receptor agonist | |||
| 0.103 | 0.083 | 0.103 | TRPA1 agonist | |||
| 0.024 | 0.005 | 0.024 | Vitamin D receptor agonist | 0.021 0.006 DB03947 | ||
| 0.048 | 0.028 | 0.079 | Purinergic P2Y antagonist | 0.079 0.013 DBMET02033 | DBMET02033 | |
| 0.094 | 0.074 | 0.094 | Gastric antisecretory | |||
| 0.043 | 0.024 | 0.043 | Dopamine D5 agonist | |||
| 0.058 | 0.039 | 0.059 | Lipocortins synthesis agonist | 0.055 0.048 DB03947 0.059 0.038 DBMET02033 | DBMET02033 | |
| 0.051 | 0.032 | 0.051 | Metalloproteinase-3 inhibitor | |||
| 0.031 | 0.012 | 0.031 | Calcium-sensing receptor agonist | |||
| 0.023 | 0.005 | 0.023 | Telomerase stimulant | 0.018 0.011 DB03947 | ||
| 0.025 | 0.007 | 0.025 | Calcium-sensing receptor antagonist | |||
| 0.021 | 0.003 | 0.021 | Purine nucleoside phosphorylase inhibitor | 0.013 0.007 DB03947 0.012 0.007 DBMET02033 | ||
| 0.041 | 0.024 | 0.041 | Vascular adhesion protein 1 inhibitor | |||
| 0.048 | 0.031 | 0.048 | Thymidylate synthase inhibitor | |||
| 0.103 | 0.086 | 0.103 | Caspase 3 inhibitor | |||
| 0.031 | 0.015 | 0.031 | MAP3K8 inhibitor | |||
| 0.036 | 0.02 | 0.036 | Sirtuin 2 inhibitor | |||
| 0.081 | 0.065 | 0.081 | NMDA receptor antagonist | |||
| 0.028 | 0.013 | 0.028 | Vanilloid 2 agonist | 0.025 0.018 DBMET02033 | ||
| 0.018 | 0.004 | 0.018 | Thromboxane agonist | 0.013 0.005 DB03947 | ||
| 0.022 | 0.007 | 0.022 | Adenosine A2 receptor agonist | |||
| 0.039 | 0.026 | 0.039 | Leukotriene C4 antagonist | |||
| 0.054 | 0.04 | 0.054 | Neuropeptide agonist | |||
| 0.061 | 0.047 | 0.061 | Nitric oxide donor | |||
| 0.035 | 0.022 | 0.035 | RNA-directed RNA polymerase inhibitor | |||
| 0.057 | 0.045 | 0.057 | Androgen agonist | |||
| 0.09 | 0.077 | 0.09 | Insulin receptor antagonist | |||
| 0.042 | 0.03 | 0.042 | GABA B receptor antagonist | |||
| 0.086 | 0.074 | 0.086 | Protein kinase C zeta inhibitor | |||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.035 | 0.023 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.016 DBMET02033 | DBMET02033 | |
| 0.02 | 0.009 | 0.033 | Prostacyclin agonist | 0.033 0.005 DB03947 | DB03947 | |
| 0.024 | 0.013 | 0.024 | ICAM 1 antagonist | |||
| 0.018 | 0.008 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 DBMET02033 | ||
| 0.073 | 0.063 | 0.096 | Sphingosine 1-phosphate receptor antagonist | 0.077 0.053 DB03947 0.096 0.024 DBMET02033 | DBMET02033 | |
| 0.114 | 0.104 | 0.114 | Neurotrophic factor | |||
| 0.02 | 0.01 | 0.02 | Cyclin T1 inhibitor | |||
| 0.019 | 0.009 | 0.019 | Prostaglandin EP4 agonist | |||
| 0.061 | 0.051 | 0.061 | Aryl hydrocarbon receptor antagonist | |||
| 0.018 | 0.009 | 0.018 | Adenosine A2a receptor agonist | |||
| 0.071 | 0.061 | 0.071 | Potassium channel (Tandem pore domain) blocker | |||
| 0.079 | 0.071 | 0.087 | Transcription factor NF kappa B stimulant | 0.087 0.055 DBMET02033 | DBMET02033 | |
| 0.027 | 0.02 | 0.027 | LFA antagonist | |||
| 0.023 | 0.015 | 0.023 | Glutamate (mGluR1a) agonist | |||
| 0.023 | 0.016 | 0.023 | Beta 1 adrenoreceptor agonist | |||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | 0.013 0.007 DBMET02033 | ||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.054 | 0.048 | 0.054 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.053 | 0.048 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.038 | 0.034 | 0.038 | Oxytocin agonist | |||
| 0.041 | 0.037 | 0.041 | AICAR transformylase inhibitor | |||
| 0.062 | 0.057 | 0.062 | Carbonic anhydrase VA inhibitor | |||
| 0.022 | 0.018 | 0.022 | Aminopeptidase P inhibitor | |||
| 0.045 | 0.041 | 0.045 | Topoisomerase II beta inhibitor | |||
| 0.037 | 0.034 | 0.037 | Neurokinin 2 antagonist | |||
| 0.031 | 0.028 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.014 | 0.011 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | |||
| 0.035 | 0.032 | 0.035 | Retinoid X receptor antagonist | |||
| 0.032 | 0.029 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.034 | 0.031 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.084 | 0.082 | 0.084 | Xanthine oxidase inhibitor | |||
| 0.031 | 0.029 | 0.031 | Retinoid X receptor agonist | |||
| 0.01 | 0.008 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET02033 | ||
| 0.033 | 0.032 | 0.033 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.036 | 0.035 | 0.036 | Glutamate (mGluR1a) antagonist | |||
| 0.021 | 0.02 | 0.021 | Retinoic acid gamma receptor agonist | |||
| 0.033 | 0.032 | 0.033 | Farnesoid X receptor agonist | |||
| 0.018 | 0.017 | 0.018 | Hexokinase stimulant | |||
| 0.018 | 0.021 | 0.025 | Lysophosphatidic acid 1 receptor antagonist | 0.025 0.009 DBMET02033 | DBMET02033 | |
| 0.056 | 0.059 | 0.063 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET02033 | DBMET02033 | |
| 0.092 | 0.102 | 0.099 | Electron transport complex I inhibitor | 0.099 0.084 DB03947 | DB03947 | |
| 0.186 | 0.2 | 0.473 | Apoptosis antagonist | 0.234 0.143 DB03947 0.473 0.024 DBMET02033 | DBMET02033 | |
| 0.005 | 0.036 | 0.021 | Purinergic P2Y agonist | 0.021 0.005 DBMET02033 | DBMET02033 | |
| 0.004 | 0.037 | 0.028 | Purinergic P2 agonist | 0.028 0.005 DBMET02033 | DBMET02033 | |
| 0.004 | 0.037 | 0.028 | Purinergic receptor agonist | 0.028 0.005 DBMET02033 | DBMET02033 | |
| 0.04 | 0.073 | 0.111 | Purinergic P2X2 antagonist | 0.111 0.025 DBMET02033 | DBMET02033 | |
| 0.024 | 0.059 | 0.035 | p53 inhibitor | 0.035 0.026 DB03947 | DB03947 | |
| 0.011 | 0.056 | 0.069 | Purinergic P2X agonist | 0.069 0.005 DBMET02033 | DBMET02033 | |
| 0.212 | 0.257 | 0.508 | Apoptosis agonist | 0.508 0.072 DBMET02033 | DBMET02033 | |
| 0.027 | 0.073 | 0.044 | Calcium-independent phospholipase A2 inhibitor | 0.044 0.007 DB03947 0.032 0.03 DBMET02033 | DB03947 | |
| 0.019 | 0.072 | 0.045 | Toll-Like receptor 4 agonist | 0.045 0.004 DBMET02033 | DBMET02033 | |
| 0.116 | 0.208 | 0.276 | Tumour necrosis factor alpha release inhibitor | 0.276 0.063 DBMET02033 | DBMET02033 | |
| 0.108 | 0.201 | 0.168 | Lipocortins synthesis antagonist | 0.168 0.083 DB03947 | DB03947 | |
| 0.069 | 0.183 | 0.156 | Folate antagonist | 0.156 0.02 DBMET02033 | DBMET02033 | |
| 0.039 | 0.172 | 0.095 | HIV-1 integrase inhibitor | 0.095 0.028 DB03947 0.082 0.036 DBMET02033 | DB03947 | |
| 0.057 | 0.199 | 0.287 | Vanilloid agonist | 0.287 0.005 DBMET02033 | DBMET02033 | |
| 0.059 | 0.203 | 0.355 | 3C-Like protease (SARS coronavirus) inhibitor | 0.355 0.003 DB03947 0.257 0.004 DBMET02033 | DB03947 | |
| 0.005 | 0.221 | 0.018 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.018 0.016 DBMET02033 | DBMET02033 | |
| 0.018 | 0.37 | 0.112 | Autotaxin inhibitor | 0.112 0.011 DBMET02033 | DBMET02033 | |
| 0.005 | 0.422 | 0.024 | Urotensin II agonist | 0.024 0.023 DBMET02033 | DBMET02033 | |
| 0.01 | 0.488 | 0.072 | Purinergic P2Y2 antagonist | 0.072 0.006 DBMET02033 | DBMET02033 | |
| 0.034 | 0.519 | 0.202 | Platelet adhesion inhibitor | 0.202 0.07 DBMET02033 | DBMET02033 | |
| 0.006 | 0.536 | 0.04 | Growth factor receptor-bound protein 2 antagonist | 0.04 0.014 DBMET02033 | DBMET02033 | |
| 0.006 | 0.741 | 0.06 | Cathepsin B inhibitor | 0.06 0.035 DB03947 | DB03947 | |
| 0.011 | 0.813 | 0.056 | Sodium/calcium exchanger inhibitor | 0.056 0.024 DBMET02033 | DBMET02033 | |
| 0.002 | 0.911 | 0.042 | Purinergic P2Y1 antagonist | 0.042 0.004 DBMET02033 | DBMET02033 | |
| 0.004 | 0.969 | 0.114 | DNA directed RNA polymerase inhibitor | 0.114 0.042 DBMET02033 | DBMET02033 | |
| 0.004 | 0.991 | 0.183 | Falcipain inhibitor | 0.183 0.019 DB03947 | DB03947 | |
| 0.003 | 0.995 | 0.167 | Falcipain 2 inhibitor | 0.167 0.022 DB03947 | DB03947 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |